Clinical Study Results
Research sponsor: MedImmune, LLC
Drug studied: MEDI3250 vaccine
Study title: A study to learn more about the safety of
the MEDI3250 flu vaccine
Thank you!
Thank you to the participants in the clinical study for the vaccine MEDI3250. All of
the participants helped researchers learn more about using the MEDI3250 vaccine
to prevent influenza, also known as the flu.
MedImmune, LLC sponsored this study and thinks it is important to share the
results. An independent non-profit organization called CISCRP helped prepare this
summary of the study results.
If you participated in the study and have questions about the results, please speak
with the doctor or staff at your study site.
What is happening with the study now?
The study has finished. The participants were in the study for about 6.5 months
and the entire study took 7 months to finish.
The study started in May 2017 and ended in December 2017. The study included
300 participants in the United States.
The sponsor reviewed the data collected when the study ended and created a
report of the results. This is a summary of that report.
1